131 related articles for article (PubMed ID: 38044783)
1. Assessment of Imaging Findings of Renal Carcinoma Subtypes with 3.0T MRI.
Nalbant MO; Inci E
Niger J Clin Pract; 2023 Nov; 26(11):1750-1757. PubMed ID: 38044783
[TBL] [Abstract][Full Text] [Related]
2. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
Oliva MR; Glickman JN; Zou KH; Teo SY; Mortelé KJ; Rocha MS; Silverman SG
AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
[TBL] [Abstract][Full Text] [Related]
3. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
Choi YA; Kim CK; Park SY; Cho SW; Park BK
AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of T1-Weighted MRI to Detect Intratumoral Hemorrhage Within Papillary Renal Cell Carcinoma as a Feature Differentiating From Angiomyolipoma Without Visible Fat.
Murray CA; Quon M; McInnes MD; van der Pol CB; Hakim SW; Flood TA; Schieda N
AJR Am J Roentgenol; 2016 Sep; 207(3):585-91. PubMed ID: 27275530
[TBL] [Abstract][Full Text] [Related]
7. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
8. Small renal cell carcinoma: MRI with pathologic correlation.
Shinmoto H; Yuasa Y; Tanimoto A; Narimatsu Y; Jinzaki M; Hiramatsu K; Mukai M
J Magn Reson Imaging; 1998; 8(3):690-4. PubMed ID: 9626888
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.
Mytsyk Y; Dutka I; Borys Y; Komnatska I; Shatynska-Mytsyk I; Farooqi AA; Gazdikova K; Caprnda M; Rodrigo L; Kruzliak P
Int Urol Nephrol; 2017 Feb; 49(2):215-224. PubMed ID: 27853915
[TBL] [Abstract][Full Text] [Related]
10. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.
Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR
AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic utility of diffusion weighted MRI imaging and ADC ratio to distinguish benign from malignant renal masses: sorting the kittens from the tigers.
de Silva S; Lockhart KR; Aslan P; Nash P; Hutton A; Malouf D; Lee D; Cozzi P; MacLean F; Thompson J
BMC Urol; 2021 Apr; 21(1):67. PubMed ID: 33888122
[TBL] [Abstract][Full Text] [Related]
13. Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.
Cornelis F; Tricaud E; Lasserre AS; Petitpierre F; Bernhard JC; Le Bras Y; Yacoub M; Bouzgarrou M; Ravaud A; Grenier N
Eur Radiol; 2014 May; 24(5):1068-80. PubMed ID: 24557052
[TBL] [Abstract][Full Text] [Related]
14. Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors.
Sevcenco S; Heinz-Peer G; Ponhold L; Javor D; Kuehhas FE; Klingler HC; Remzi M; Weibl P; Shariat SF; Baltzer PA
Eur J Radiol; 2014 Jun; 83(6):909-913. PubMed ID: 24709332
[TBL] [Abstract][Full Text] [Related]
15. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
Halefoglu AM; Ozagari AA
Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
[TBL] [Abstract][Full Text] [Related]
16. Small (< 4 cm) Renal Tumors With Predominantly Low Signal Intensity on T2-Weighted Images: Differentiation of Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma.
Park JJ; Kim CK
AJR Am J Roentgenol; 2017 Jan; 208(1):124-130. PubMed ID: 27824487
[TBL] [Abstract][Full Text] [Related]
17. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?
Hindman N; Ngo L; Genega EM; Melamed J; Wei J; Braza JM; Rofsky NM; Pedrosa I
Radiology; 2012 Nov; 265(2):468-77. PubMed ID: 23012463
[TBL] [Abstract][Full Text] [Related]
18. The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes.
Serter A; Onur MR; Coban G; Yildiz P; Armagan A; Kocakoc E
Abdom Radiol (NY); 2021 Mar; 46(3):1041-1052. PubMed ID: 32930832
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging as a biomarker in renal cell carcinoma.
Pedrosa I; Alsop DC; Rofsky NM
Cancer; 2009 May; 115(10 Suppl):2334-45. PubMed ID: 19402070
[TBL] [Abstract][Full Text] [Related]
20. Are Hemorrhagic Cysts Hyperintense Enough on T1-Weighted MRI to Be Distinguished From Renal Cell Carcinomas? A Retrospective Analysis of 204 Patients.
McKee TC; Dave J; Kania L; Karajgikar J; Masarapu V; Deshmukh S; Roth C
AJR Am J Roentgenol; 2019 Dec; 213(6):1267-1273. PubMed ID: 31532256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
